THREE TNF-A-INHIBITORS FOR TREATMENT OF RHEUMATOID ARTHRITIS, ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS

被引：0
|
作者：
Ivakhnenko, O. [1 ]
Rebrova, O. [2 ]
Avxentyeva, M. [3 ]
Khachatryan, G. [1 ]
机构：
[1] Autonomous Nonprofit Org, Natl Ctr Hlth Technol Assessment, Moscow, Russia
[2] Pirogov Russian Natl Res Med Univ, Moscow, Russia
[3] Russian Presidential Acad Natl Econ & Publ Adm, Moscow, Russia
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 07期
关键词：
D O I：
10.1016/j.jval.2013.08.1498
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A564 / A564
页数：1
相关论文
共 50 条
  • [31] Efficacy of tofacitinib in reducing pain in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis
    Ogdie, Alexis
    de Vlam, Kurt
    McInnes, Iain B.
    Mease, Philip J.
    Baer, Philip
    Lukic, Tatjana
    Gruben, David
    Kwok, Kenneth
    Wang, Cunshan
    Hsu, Ming-Ann
    Maniccia, Anna
    RMD OPEN, 2020, 6 (01):
  • [32] Impact of treatment with TNF antagonists on total cholesterol in patients with ankylosing spondylitis and psoriatic arthritis
    Ramon Maneiro, Jose
    Souto, Alejandro
    Gomez-Reino, Juan J.
    CLINICAL RHEUMATOLOGY, 2017, 36 (05) : 1167 - 1172
  • [33] MALIGNANCY IN THE UPADACITINIB CLINICAL TRIAL PROGRAMS FOR RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, AND ANKYLOSING SPONDYLITIS
    Rubbert-Roth, Andrea
    Kakehasi, Adriana
    Takeuchi, Tsutomu
    Schmalzing, Marc
    Palac, Hannah
    Liu, Jianzhong
    Anyanwu, Samuel
    Lippe, Ralph
    Nash, Peter
    Curtis, Jeffrey
    INTERNAL MEDICINE JOURNAL, 2023, 53 : 44 - 44
  • [34] The eye and inflammatory rheumatic diseases: The eye and rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis
    Murray, Philip Ian
    Rauz, Saaeha
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2016, 30 (05): : 802 - 825
  • [35] A QUANTITATIVE ASSESSMENT OF ADHERENCE TO DMARDS IN PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS
    Raghunath, S.
    Dissanayake, K.
    Goldblatt, F.
    INTERNAL MEDICINE JOURNAL, 2017, 47 : 17 - 17
  • [36] Malignancy in the Upadacitinib Clinical Trial Programs for Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis
    Rubbert-Roth, Andrea
    Kakehasi, Adriana
    Takeuchi, Tsutomu
    Schmalzing, Marc
    Palac, Hannah
    Liu, Jianzhong
    Anyanwu, Samuel
    Lippe, Ralph
    Curtis, Jeffrey
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 562 - 564
  • [37] Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis
    Han, Chenglong
    Robinson, Don W.
    Hackett, Monica V.
    Paramore, L. Clark
    Fraeman, Kathy H.
    Bala, Mohan V.
    JOURNAL OF RHEUMATOLOGY, 2006, 33 (11) : 2167 - 2172
  • [38] Impact of treatment with TNF antagonists on total cholesterol in patients with ankylosing spondylitis and psoriatic arthritis
    Jose Ramon Maneiro
    Alejandro Souto
    Juan J. Gomez-Reino
    Clinical Rheumatology, 2017, 36 : 1167 - 1172
  • [39] PATIENT CHARACTERISTICS AND GOLIMUMAB UTILIZATION IN RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, AND ANKYLOSING SPONDYLITIS PATIENTS
    Tandon, N.
    Haas, S.
    Bolge, S.
    Gunnarsson, C.
    VALUE IN HEALTH, 2012, 15 (04) : A48 - A48
  • [40] DIFFERENCES IN PROINFLAMMATORY AND LIPID PROFILE BETWEEN PSORIATIC ARTHRITIS, ANKYLOSING SPONDYLITIS AND RHEUMATOID ARTHRITIS
    Bonek, K.
    Kuca-Warnawin, E.
    Ciechomska, M.
    Gluszko, P.
    Kontny, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 822 - 822
12345